Related Experiment Video

Updated: Aug 18, 2026

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Single dose azithromycin for the treatment of uncomplicated otitis media

Adriano Arguedas1, Cecilia Loaiza, Carolina Soley

  • 1Instituto de Atención Pediátrica and Universidad de Ciencias Médicas, San José, Costa Rica. aarguedas@iped.net

The Pediatric Infectious Disease Journal
|February 11, 2004
PubMed

Insights

Single dose azithromycin (30 mg/kg) offers a safe and effective treatment for children with uncomplicated acute otitis media (AOM). This regimen showed comparable efficacy and improved compliance versus traditional treatments.

Area of Science:

  • Pediatric infectious diseases
  • Pharmacology and therapeutics
  • Clinical microbiology

Background:

  • Acute otitis media (AOM) is a common childhood infection requiring effective antimicrobial treatment.
  • Current AOM treatment guidelines often involve multi-day oral antibiotic courses.
  • Optimizing antibiotic regimens for AOM can improve treatment outcomes and patient compliance.

Purpose of the Study:

  • To evaluate the efficacy and safety of a single-dose azithromycin regimen (30 mg/kg) for uncomplicated AOM in children.
  • To compare single-dose azithromycin with other standard AOM treatments in clinical trials.
  • To assess the safety profile and patient compliance associated with single-dose azithromycin therapy.

Main Methods:

  • Three clinical trials were conducted, including a pilot study, a non-comparative trial, and a large double-blind, double-dummy trial.
  • Efficacy was assessed through clinical and microbiologic outcomes.
  • Safety was monitored by recording drug-related adverse events.
  • Patient compliance was compared between single-dose azithromycin and a 10-day amoxicillin/clavulanate regimen.

Main Results:

  • Single-dose azithromycin demonstrated clinical and microbiologic efficacy comparable to 3-day azithromycin and single-dose ceftriaxone in the initial trials.
  • A subsequent large trial confirmed comparable clinical success rates between single-dose azithromycin and 10-day amoxicillin/clavulanate.
  • Adverse event rates for single-dose azithromycin were low and similar to other AOM treatments.
  • Significantly better compliance was observed with single-dose azithromycin compared to the amoxicillin/clavulanate regimen (P < 0.001).

Conclusions:

  • A single dose of azithromycin (30 mg/kg) is a safe and effective option for treating uncomplicated acute otitis media in children.
  • The single-dose regimen offers a convenient alternative with improved patient compliance.
  • Further research may support the integration of single-dose azithromycin into standard AOM treatment protocols.

More Related Videos

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity09:52

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on: March 16, 2018

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment08:33

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment

Published on: November 17, 2018

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Dosage Regimen: Multiple Oral Dosage01:25

Dosage Regimen: Multiple Oral Dosage

Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...